Recent advances with recombinant bacterial vaccine vectors

This publication has 53 references indexed in Scilit:

• Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Secreting Merozoite Surface Protein 1 (MSP1) Induces Protection against Rodent Malaria Parasite Infection Depending on MSP1-stimulated Interferon γ and Parasite-specific Antibodies
  The Journal of Experimental Medicine, 1998
• Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up
  Vaccine, 1996
• Bacterial Enteric Infections in Persons Infected with Human Immunodeficiency Virus
  Clinical Infectious Diseases, 1995
• Highly Attenuated HIV Type 2 Recombinant Poxviruses, but Not HIV-2 RecombinantSalmonellaVaccines, Induce Long-Lasting Protection in Rhesus Macaques
  AIDS Research and Human Retroviruses, 1995
• Live AttenuatedShigella flexneriMutants as Vaccine Candidates Against Shigellosis and Vectors for Antigen Delivery
  Biologicals, 1995
• Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes.
  The Journal of Experimental Medicine, 1994
• Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches.
  The Journal of Experimental Medicine, 1994
• Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial
  Vaccine, 1990
• Genetic transformation of BCG
  Tubercle, 1989
• Strategies for Elimination of Poliomyelitis in Different Parts of the World with Use of Oral Poliovirus Vaccine
  Clinical Infectious Diseases, 1984